About TELA Bio, Inc.
https://www.telabio.comTELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy.
CEO
Antony Koblish
Compensation Summary
(Year 2019)
ETFs Holding This Stock
Summary
Showing Top 3 of 13
Ratings Snapshot
Rating : D+
Most Recent Analyst Grades
Lake Street
Buy
Canaccord Genuity
Buy
Citizens
Market Outperform
Citizens Capital Markets
Market Outperform
Piper Sandler
Neutral
Grade Summary
Showing Top 5 of 5
Price Target
Institutional Ownership
NANTAHALA CAPITAL MANAGEMENT, LLC
Shares:5.11M
Value:$5.16M
ESSEX WOODLANDS MANAGEMENT, INC.
Shares:4.11M
Value:$4.15M
SILVERARC CAPITAL MANAGEMENT, LLC
Shares:2.78M
Value:$2.81M
Summary
Showing Top 3 of 45
About TELA Bio, Inc.
https://www.telabio.comTELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $20.69M ▲ | $21.52M ▼ | $-8.6M ▲ | -41.58% ▲ | $-0.19 ▲ | $-7.15M ▲ |
| Q2-2025 | $20.2M ▲ | $23.19M ▲ | $-9.92M ▲ | -49.13% ▲ | $-0.22 ▲ | $-8.43M ▲ |
| Q1-2025 | $18.52M ▲ | $22.98M ▲ | $-11.26M ▼ | -60.82% ▼ | $-0.25 ▼ | $-9.73M ▼ |
| Q4-2024 | $17.65M ▼ | $19.57M ▼ | $-9.21M ▲ | -52.17% ▲ | $-0.23 ▲ | $-7.8M ▲ |
| Q3-2024 | $18.96M | $22.22M | $-10.37M | -54.71% | $-0.42 | $-8.77M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $29.71M ▼ | $61.59M ▼ | $60.03M ▲ | $1.56M ▼ |
| Q2-2025 | $34.98M ▼ | $67.54M ▼ | $58.35M ▼ | $9.18M ▼ |
| Q1-2025 | $42.83M ▼ | $77.25M ▼ | $59.13M ▲ | $18.12M ▼ |
| Q4-2024 | $52.67M ▲ | $87.33M ▲ | $58.87M ▼ | $28.46M ▲ |
| Q3-2024 | $17.3M | $53.02M | $59.29M | $-6.27M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-8.6M ▲ | $-5.72M ▲ | $312K ▲ | $24K ▲ | $-5.26M ▲ | $-5.93M ▲ |
| Q2-2025 | $-9.92M ▲ | $-7.91M ▲ | $204K ▲ | $-3K ▲ | $-7.86M ▲ | $-8.02M ▲ |
| Q1-2025 | $-11.26M ▼ | $-9.72M ▼ | $138K ▲ | $-116K ▼ | $-9.84M ▼ | $-9.76M ▼ |
| Q4-2024 | $-9.21M ▲ | $-7.53M ▲ | $-190K ▼ | $42.91M ▲ | $35.37M ▲ | $-7.79M ▲ |
| Q3-2024 | $-10.37M | $-8.98M | $-122K | $98K | $-9.2M | $-9.11M |
Revenue by Geography
| Region | Q4-2024 | Q2-2025 | Q1-2025 | Q3-2025 |
|---|---|---|---|---|
 NonUS | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
Antony Koblish
Compensation Summary
(Year 2019)
ETFs Holding This Stock
Summary
Showing Top 3 of 13
Ratings Snapshot
Rating : D+
Most Recent Analyst Grades
Lake Street
Buy
Canaccord Genuity
Buy
Citizens
Market Outperform
Citizens Capital Markets
Market Outperform
Piper Sandler
Neutral
Grade Summary
Showing Top 5 of 5
Price Target
Institutional Ownership
NANTAHALA CAPITAL MANAGEMENT, LLC
Shares:5.11M
Value:$5.16M
ESSEX WOODLANDS MANAGEMENT, INC.
Shares:4.11M
Value:$4.15M
SILVERARC CAPITAL MANAGEMENT, LLC
Shares:2.78M
Value:$2.81M
Summary
Showing Top 3 of 45